RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculatureKai Temming, Robbert J. Kok, Raymond M. Schiffelers et al.|Drug Resistance Updates|2005Cited by 461
A Liposomal System for Contrast-Enhanced Magnetic Resonance Imaging of Molecular TargetsWillem J. M. Mulder, Klaas Nicolay, Gustav J. Strijkers et al.|Bioconjugate Chemistry|2004Cited by 233
Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate–containing RGD peptide liposomes inhibits experimental arthritisGerben A. Koning, Gert Storm, Raymond M. Schiffelers et al.|Arthritis & Rheumatism|2006Cited by 182
Differential effects of NF-κB and p38 MAPK inhibitors and combinations thereof on TNF-α- and IL-1β-induced proinflammatory status of endothelial cells in vitroJoanna Kuldo, Grietje Molema, Johanna Westra et al.|American Journal of Physiology-Cell Physiology|2005Cited by 158
Preparation and Functional Evaluation of RGD-Modified Proteins as α<sub>v</sub>β<sub>3</sub> Integrin Directed TherapeuticsRobbert J. Kok, Grietje Molema, Astrid J. Schraa et al.|Bioconjugate Chemistry|2001Cited by 146